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Abstract
Background: Severity of illness (SOI) is an All Patients Refined Diagnosis Related Groups (APR DRG) modifier based
on comorbidity capture. Tracking SOI helps hospitals improve performance and resource distribution. Furthermore,
benchmarking SOI plays a key role in Quality Improvement (QI) efforts such as Clinical Documentation Improvement
(CDI) programs. The current SOI system highly relies on the 3 M APR DRG grouper that is updated annually, making it
difficult to track severity longitudinally and benchmark against hospitals with different patient populations. Here, we
describe an alternative SOI scoring system that is grouper-independent and that can be tracked longitudinally.
Methods: Admission data for 2019–2020 U.S. News and World Report Honor Roll facilities were downloaded from
the Vizient Clinical Database and split into training and testing datasets. Elixhauser comorbidities, body systems
developed from the Healthcare Cost and Utilization Project (HCUP), and ICD-10-CM complication and comorbidity
(CC/MCC) indicators were selected as the predictors for orthogonal polynomial regression models to predict patients’
admission and discharge SOI. Receiver operating characteristic (ROC) and Precision-Recall (PR) analysis, and prediction
accuracy were used to evaluate model performance.
Results: In the training dataset, the full model including both Elixhauser comorbidities and body system CC/MCC
indicators had the highest ROC AUC, PR AUC and predication accuracy for both admission (ROC AUC: 92.9%; PR AUC:
91.0%; prediction accuracy: 85.4%) and discharge SOI (ROC AUC: 93.6%; PR AUC: 92.8%; prediction accuracy: 86.2%).
The model including only body system CC/MCC indicators had similar performance for admission (ROC AUC: 92.4%;
PR AUC: 90.4%; prediction accuracy: 84.8%) and discharge SOI (ROC AUC: 93.1%; PR AUC: 92.2%; prediction accuracy:
85.6%) as the full model. The model including only Elixhauser comorbidities exhibited the lowest performance. Similarly, in the validation dataset, the prediction accuracy was 86.2% for the full model, 85.6% for the body system model,
and 79.3% for the comorbidity model. With fewer variables and less model complexity, the body system model was
more efficient and was determined to be the optimal model. The probabilities generated from this model, named J_
Score and J_Score_POA, successfully measured SOI and had practical applications in assessment of CDI performance.
Conclusions: The J_Scores generated from the body system model have significant value in evaluating admission
and discharge severity of illness. We believe that this new scoring system will provide a useful tool for healthcare institutions to benchmark patients’ illness severity and augment Quality Improvement (QI) efforts.
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Background
Healthcare
institutions
increasingly
emphasize
improved outcomes and performance and focus efforts
to improve quality of care and patient safety while
lowering costs [1, 2]. They cannot determine whether
their efforts are satisfactory without tracking outcomes
and comparing with peers, so benchmarking is widely
applied within healthcare organizations to improve
their clinical performance and management of operations [3–5]. Hospitals have also started Clinical Documentation Improvement (CDI) programs to improve
documentation quality; these programs ensure better
patient outcomes, optimized data quality and accurate
reimbursement [6, 7].
Vizient is the largest member-driven health care performance improvement company in the U.S. and it provides services to about 95% of the nation’s academic
medical centers and more than 50% of the nation’s acute
care health systems [8]. Using data collected by Vizient,
members can benchmark many key performance indicators such as Case Mix Index (CMI), Length of Stay
(LOS), Expected Risk of Mortality (EROM), and Severity of Illness (SOI) [9–12]. SOI describes the disease
severity in hospitalized patients and measures the physical effects of disease on a patient. It is a powerful tool
to track resource consumption and to track patient outcomes. In addition, SOI is also closely related to cost,
revenue, and profit [13]. The admission and discharge
SOI are created by the 3 M coding algorithm. The
admission SOI is important for hospitals to measure the
health status and severity of illness of a patient when
he/she is admitted. Hospitals can use admission SOI to
estimate resource distribution. Discharge SOI can be
used for prospective payment and risk adjustment in
quality reporting. Benchmarking SOI helps hospitals
better evaluate their clinical performance and distribution of resources by comparing them to peers. The
SOI levels presented in Vizient data come from the All
Patients Refined Diagnosis Related Groups (APR DRG)
classification system developed by 3M [14, 15] Each
APR DRG has four categorical severity levels: minor,
moderate, major and extreme. The SOI subclasses are
related to the APR DRG grouper that is updated annually by 3M. However, there are several limitations using
the current SOI system. Firstly, cross-category comparison of disease severity is less meaningful. The same
SOI level from different APR DRG does not mean the
same level of disease burden. Secondly, it is hard to

compare severity among institutions because of each
institution’s unique patient mix. Lastly, it is difficult
to track yearly clinical performance using longitudinal
data, given that the grouper is updated annually. Therefore, we sought to develop a novel measure of SOI that
is grouper independent.
To find the appropriate predictors, we compared several models targeting Elixhauser comorbidities, body
systems for chronic condition indicators, and complication or comorbidity (CC) or major complication or
comorbidity indicators (MCC) [16–19]. The Elixhauser
comorbidities are a comprehensive set of measures to
identify different pre-existing conditions based on secondary diagnoses listed in hospital administrative data.
The system was developed by Anne Elixhauser using
all adult, nonmaternal inpatients from acute care hospitals in California in 1992 [20]. It includes 30 comorbidity measures that are associated with considerable
increases in LOS, hospital charges, and mortality. The
comorbidities are usually not directly related to the
primary reason for the inpatient stay, but they have a
possible effect on outcomes used to assess the quality
of care. The Agency for Healthcare Research and Quality (AHRQ) has created a powerful Healthcare Cost
and Utilization Project (HCUP) tool called Elixhauser
Comorbidity Software Refined for ICD-10-CM, which
can be applied to ICD-10 diagnosis codes to create a
comorbidity profile [16, 17]. AHRQ also created another
tool to categorize ICD-10-CM codes into 18 body systems [19]. Body systems allow us to correct for regional
differences in patient mix and comorbidity-driven
DRG modifiers, so that we can compare the intensity of
severity that is independent on types of diseases. These
tools provide the potential indicators for predicting the
severity of illness. Another valuable resource is the list
of all of the ICD-10 codes that are defined as either a CC
or MCC diagnoses, released by Center for Medicare &
Medicaid Services (CMS) [21]. We combined CC/MCC
levels with body systems and created a 3-level indicator
for each body system, indicating whether the body system has any CC or MCC diagnosis code. In this study,
the Elixhauser comorbidities and 18 body systems with
CC/MCC indicators were used as predictors to evaluate case severity. Instead of predicting four categorized
SOI levels, we aimed to develop a model to better predict high and low illness severity that is independent of
APR DRG assignment. Additionally, the probabilities
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generated from the model would be used as a quantitative measurement of SOI.

Methods
Data Sources

This study included 923,266 inpatient cases discharged
between July 
1st, 2018 and June 3
0th, 2019 from the
2019–2020 U.S. News and World Report Best Hospitals Honor Roll [22]. All cases used the same version of
APR DRG. This study included adult inpatients with
age >  = 18 (including maternity). Hospital encounters
classified as inpatient status were included. Observation, Emergency Department, and Outpatient encounters
were not included. Patients may be admitted multiple
times; each hospital admission is a separate encounter in
the study. Patients’ clinical data were downloaded from
Vizient Clinical Data Base (CDB). Body system categories and Elixhauser Comorbidity indicators came from
HCUP [16, 19]. The list of CC/MCC diagnosis codes was
downloaded from the FY2019 CMS final rule and correction notice data files [21, 23]. Information related to case
review and query by clinical documentation specialists
came from an internal database within our institution.
All the data used in this study were deidentified before
analysis in accordance with HIPPA guidelines.
Independent Variables and Outcome

In this paper, we predicted both admission and discharge
SOI. All the diagnosis codes from a patient were used to
predict the SOI at discharge, and only the present-onadmission (POA) and exempt diagnosis codes were used
to predict the SOI on admission [24].
Body system CC/MCC level indicators

ICD-10 diagnosis codes were grouped into 18 body systems using HCUP software [19]. We combined the body
system indicators and CC/MCC levels to create 18 variables. Each ordinal variable had three severity levels: 0,
1, and 2. Level 0 represented no diagnosis code in the
specific body system. Level 1 represented there were
one or more diagnosis codes in the body system, but
none of them were CC or MCC codes. Level 2 indicated
there was at least one CC or MCC diagnosis code in the
body system.
Elixhauser comorbidity indicators

Elixhauser comorbidities were generated from Elixhauser
comorbidity software v2019.2 (beta version) and SAS analysis program (COMOANALY_ICD10CM_2019_1.sas)
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that were downloaded from HCUP [17]. Each variable
indicated whether the patient had a specific type of Elixhauser comorbidity based on the secondary diagnosis
codes.
Outcome

APR DRG SOI minor and moderate levels (SOI = 1 or 2)
were grouped into a low severity category, and major and
extreme levels (SOI = 3 or 4) were considered as high severity. Our models predicted the probability of being a high SOI
case, so, the outcome is a binary response variable. The probabilities calculated from the model were named J_Score_
POA for admission SOI and J_Score for discharge SOI,
which can be used to quantitatively measure the severity.
Variable Selection and Model Validation

Data were randomly split into training and testing datasets in a ratio of three to one. Orthogonal polynomial
regression was applied to the training dataset [25–28].
Three models were constructed and compared: the
full model, the comorbidity model, and the body system model. The full model included all the Elixhauser
comorbidities and 18 body systems with 3 levels of CC/
MCC indicators (48 variables), the comorbidity model
only included Elixhauser comorbidities (30 variables),
and the body system model only involved body system
CC/MCC indicators (18 variables). Receiver Operating
Characteristic (ROC) and Precision-Recall (PR) analysis,
together with prediction accuracy were used to measure the performance of the classification models [29,
30]. Prediction accuracy was identified as the percentage of correctly classified cases using the optimal cutoff
points from ROC curves. Finally, models were applied to
the independent testing dataset to predict the category
of case severity using optimal cut-off points obtained
from the training dataset. For admission SOI, the optimal cutoff points were 0.422 for the full model, 0.413
for the comorbidity model, and 0.411 for the body system model. For discharge SOI, the optimal cutoff points
were 0.401 for the full model, 0.407 for the comorbidity
model, and 0.412 for the body system model.
Statistical analyses

Descriptive statistics (counts, mean, and proportions)
were used to examine the similarity between training and testing datasets. The optimal cutoff point was
defined as the value that minimizes the Euclidean distance between the ROC curve and the upper left corner
of the graph using the training dataset. All the statistical
analyses were performed in RStudio software (version
1.3.959). Statistical significance was defined as p < 0.05.
No imputations were performed in the analysis.
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Results
Characteristics of discharged cases

Nine hundred twenty-three thousand two hundred
sixty-six discharged cases extracted from the Vizient
Clinical Data Base were randomly split into training
data (692,450 cases) and testing data (230,816 cases).
We first compared the patients’ demographic and clinical information (Table 1). The mean age of patients
from two datasets was 49 years old. Around 53% of
patients were female, and the distribution of race categories was also very close (63% White, 15% Black, 5%
Asian, and 11% other race). Patients in both data sets
also had comparable admit and discharge APR DRG
SOI levels.
We then further looked at patients’ Elixhauser
comorbidities and the MS-DRG complication and
comorbidity (CC or MCC) diagnosis indicators in
Clinical Classifications Software Refined (CCSR) body
systems (Supplementary table 1). Patients in the two
datasets had similar proportions of the 30 Elixhauser
comorbidities and three CC/MCC levels in 18 body
systems. Hypertension (HTN) and fluid, electrolyte
disorders (LYTES), deficiency anemias (ANEMDEF)
and chronic pulmonary disease (CHRNLUNG) were
the top 4 comorbidities observed in patients: about
26% of patients with HTN, 24% with LYTES, 18% with
ANEMDEF, and 17% with CHRNLUNG. Body systems
3 (Endocrine; nutritional; and metabolic diseases and
immunity disorders), 7 (Diseases of the circulatory system) and 10 (Diseases of the genitourinary system) had

the greatest number of patients with CC or MCC diagnosis codes. Overall, the training data and testing data
samples were similar in both demographic and clinical
characteristics.
J_Scores generated from the body system model were
reliable for predicting case severity

We applied three orthogonal polynomial regression
models to the training data to predict the severity levels
of each case. The prediction of admission and discharge
SOI used the same algorithm; they differ based on diagnoses present on admission and discharge, respectively.
To evaluate the performance, we examined ROC curves
and PR curves. As shown in Fig. 1, when using all the
diagnosis codes to map the Elixhauser comorbidities and
body system CC/MCC indicators in discharge SOI models, the full model and body system model demonstrated
similar AUC scores in both ROC curves (93.6% and
93.1%) and PR curves (92.8% and 92.2%). The comorbidity model had the lowest AUC (ROC: 86.1%, PR: 85.0%).
In the admission SOI models, including only the POA
diagnosis codes, the full model and body system model
also outperformed the comorbidity model.
To validate the performance of the models, we checked
the prediction accuracy in the testing dataset using optimal cutoff points obtained from the training dataset as
described above (Table 2). For discharge SOI, the full
model had a prediction accuracy of 86.2%. The body system accuracy was 85.6%. The comorbidity model had the
lowest prediction accuracy (79.3%). Similar results were

Table 1 Distribution of Patients’ demographic characteristics and severity of illness for training dataset and testing dataset
Level

Training Data

Age

Mean

Sex

Male

322,458 (46.57%)

107,758 (46.69%)

Female

369,974 (53.43%)

123,051 (53.31%)

White

433,941 (62.67%)

144,910 (62.78%)

Black

101,392 (14.64%)

33,795 (14.64%)

Race

Admit APR-DRG SOI

49.01

Asian

36,688 (5.30%)

11,860 (5.14%)

Other

73,422 (10.60%)

24,432 (10.60%)

Unavailable

33,505 (4.84%)

11,308 (4.90%)

Declined

11,834 (1.71%)

3975 (1.71%)

Unknown
Discharge APR-DRG SOI

49.09

Testing Data

1668 (0.24%)

536 (0.23%)

1

161,149 (23.27%)

53,824 (23.32%)

2

227,454 (32.85%)

75,710 (32.80%)

3

205,154 (29.63%)

68,098 (29.50%)

4

98,693 (14.25%)

33,184 (14.38%)

1

177,235 (25.60%)

59,225 (25.66%)

2

238,968 (34.51%)

79,329 (34.37%)

3

198,686 (28.69%)

66,228 (28.69%)

4

77,561 (11.20%)

26,034 (11.28%)

p-value
0.22
0.58
0.09

0.39

0.53
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Fig. 1 ROC curves and Precision-Recall curves for regression models predicting admission and discharge SOI

observed in the admission SOI models using POA diagnosis codes.
We also analyzed the proportion of cases with high
admission severity for our institution and other 20192020 U.S. News and World Report Honor Roll hospitals, by comparing 3M APR DRG SOI obtained from
Vizient and the predicted results from the three models

(Supplementary Fig. 1). The trends from the full model
and the body system model approximated the measured APR DRG SOI. Consistent with previous results,
the comorbidity model displayed the largest deviation. Although the full model and the body system
model showed similar performance, the body system
model exhibited greater efficiency by only including
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Table 2 Prediction accuracy of models for predicting admission and discharge SOI
Discharge SOI

Count of Variables Prediction Accuracy False Positive Rate

False Negative Rate

Full model

48

7.03%

Comorbidity only

30

79.29%

9.79%

10.92%

Body System CCMCC only 18

85.59%

7.28%

7.13%

86.17%

6.80%

Admission SOI

Count of Variables Prediction Accuracy False Positive Rate

False Negative Rate

Full model

48

6.77%

Comorbidity only

30

77.50%

11.20%

11.30%

Body System CCMCC only 18

84.82%

8.30%

6.88%

85.41%

7.82%

18 predictors while the full model had 48. In summary,
based on the ROC analysis, precision recall analysis, prediction accuracy and counts of predictors, the body system model was determined to be the optimal model.
Besides prediction of categorical severity levels, the
probability generated from the body system model also
indicated the chance a case would be high severity. We
referred to these probabilities as “J_Scores.” J_Scores
have two versions, J_Score and J_Score_POA, depending on what diagnosis codes are used. J_Score is based on
all the diagnoses coded on a case. J_Score_POA is based
on only the present-on-admission (POA) and exempt
diagnoses. A higher J_Score indicates more severity. To
further demonstrate the J_Scores, we calculated J_Score
and J_Score_POA for all the 923,266 inpatient cases, and
then plotted the histograms to check their distribution
(Fig. 2). As shown in Fig. 2, the histograms were bimodal
with one peak at each end, indicating that the body system model performed well in separating the high and low
severity cases. Notably, approximately 6.3% of the cases
had a J_Score_POA of 1, and 9.1% of the cases had an
overall J_Score of 1.

Fig. 2 Distribution of J_Score_POA and J_Score

Utilization of J_Scores in benchmarking and clinical
documentation improvement

To further illustrate the value of J_Scores in benchmarking and CDI, we analyzed the trend of average J_Score
and J_Score_POA for our institution and the other 2019–
2020 US News and World Report Honor Roll hospitals
(Fig. 3). Not surprisingly, the average J_Score was higher
than the J_Score_POA, reflecting that more symptoms
were identified, and more diagnosis codes were added
after admission. The slightly increasing trend of J_Scores
shows that the cases discharged in 2019 had higher
severity than discharged cases in 2018. The gap between
J_Score_POA and J_Score indicated non-POA problems
that were found and treated during patients’ hospital stay.
Another application of J_Scores is to assess the performance of our Clinical Documentation Improvement program. We looked at the J_Scores for inpatient cases that
had been reviewed or queried by clinical documentation
specialists (CDS) (Fig. 4). Notably, the average J_Score_
POA of CDS reviewed cases were much higher than nonreviewed cases, indicating that CDS were selecting cases
with higher severity for review. The average J_Score was
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Fig. 3 Trend of average J_Score and J_Score_POA

Fig. 4 Trend of J_Score and J_Score_POA for cases reviewed or queried by clinical documentation specialists
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notably higher than the average of J_Score_POA for CDS
reviewed or queried cases while the averages of J_Score_
POA and J_Score were similar for non-reviewed or nonqueried cases, suggesting that CDS activities are helpful
in capturing illness severity and improving the quality of
documentation.

Discussion
In this study, we sought to develop a consistent measure of severity that is independent from the APR DRG
grouper. To achieve this goal, we mapped diagnosis codes
to Elixhauser comorbidities, CCI body systems, and CC/
MCC indicators to create predictors and then applied
orthogonal polynomial regression models to predict case
severity of illness. This method can be used as an alternative way to estimate patients’ severity. We compared
three models by evaluating their performance through
ROC analysis, prediction accuracy, and the counts of
predictors. Eventually, the body system model with CC/
MCC indicators was considered the best because of
higher AUC, higher accuracy rate and fewer variables.
The probabilities calculated from this model were named
“J_Scores,’’ which serve as a measure of severity. Then,
we compared the severity obtained from our model with
APR DRG SOI levels acquired from the Vizient database
and found that the proportions of high severity cases
were similar, indicating that our model had great value
in benchmarking (Supplemental Fig. 1). Plus, the large
sample size of patients from 21 facilities ensured reliable
results.
Although J_Scores exhibit great values in evaluating
severity, the methodology differs from APR DRG SOI.
The SOI subclasses developed from 3 M are determined
from 3 phases with 18 steps in total after the APRDRG
is assigned to a patient, incorporating the secondary
diagnoses, the impact of principal diagnosis, age, OR
procedure, non-OR procedures, and multiple OR procedures [31]. Each APR DRG has four subclasses of SOI.
However, the severity scores generated from our model
are based on affected body systems and their complication and comorbidity (CC) levels, which are not specified
for APR DRG grouper. One caveat of our model is that
the optimistic and promising predictive ability for severity is based on adult inpatient cases, and it needs to be
validated in pediatric inpatients because pediatric cases
do not have the same patterns of comorbidities as adults.
Additionally, the model needs to be refreshed or re-evaluated annually to make sure it incorporates the latest version of the diagnosis codes from CMS and the updates on
the body system assignment from AHRQ.
In our institution, we applied J_Scores to Vizient data to
benchmark severity of illness and integrated J_Scores in
CDI analysis. It was found that the average J_Score_POA
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of cases selected for review by CDS were much higher
than the J_Score_POA of cases not selected, suggesting
that our CDS were targeting cases with higher severity for review. We also envision the utility of J_Scores in
audit processes, given that effective post-coding audits
include a review of high-risk MS-DRGs, SOI, and risk of
mortality.

Conclusions
In this study, we developed a novel method to measure SOI using diagnoses with body system and CC/
MCC indicators. It is independent from APR DRG and
can be used to better evaluate or compare severity in
patients from different disease categories. The results
demonstrated that J_Scores generated from the body
system model offer reliable predictability of patients’
illness severity on admission and at discharge. Overall, this new scoring system provides a useful tool for
hospitals to benchmark SOI, assess CDI programs and
direct case review to improve clinical performance and
quality.
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